… and adult patients who develop graft versus host disease (GVHD) resistant to conventional
… Extracorporeal photochemotherapy studies in patients with acute graft-versus-host disease …

… Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell
lymphoma and graft-versus-host disease patients. Br J Haematol. 1999 Dec;107(4):707–11. …

… Extracorporeal photopheresis is one of several secondary therapies which have shown …
the use of extracorporeal photopheresis for the treatment of graft-versus-host disease including …

… Graft-versus-host disease (GvHD) is a serious complication of allogeneic hematopoietic cell
… Extracorporeal photopheresis (ECP) has objective activity in the treatment of both acute and …

… chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective …
Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous …

… , chronic graft-versus-host disease (cGVHD) remains a cause of major long-term morbidity
in survivors of allogeneic stem cell transplantation. Extracorporeal photopheresis (ECP) is a …

… objective responses of skin and visceral GVHD to extracorporeal photopheresis. All of these
results indicate activity of extracorporeal photopheresis in acute and chronic GVHD, which …

… graft-versus-host disease (GvHD) are … extracorporeal photopheresis (ECP), a
leukapheresis-based immunomodulatory treatment frequently applied in T-cell mediated immune …

… Extracorporeal photopheresis (ECP), also known as extracorporeal photochemotherapy,
involves ex vivo exposure of mononuclear cells obtained by apheresis to a photosensitizing …

… Extracorporeal photopheresis (ECP) is one of the most used and established therapies for
steroid-refractory graft-vs-host disease (GvHD), with a good effect to side effect profile. In this …